Should women with human immunodeficiency virus be delivered by cesarean?

Obstetrics and Gynecology

Volumn 94, Issue 5, 1999, Pages 799-801

  Star, Jami ^a   Powrie, Raymond ^a   Cu Uvin, Susan ^a   Carpenter, Charles C J ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

CESAREAN SECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREGNANCY; PRIORITY JOURNAL; RISK; SHORT SURVEY; VIRUS LOAD; VIRUS TRANSMISSION;

CESAREAN SECTION; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0033231679     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/00006250-199911000-00031     Document Type: Editorial

References (12)

1. Centers for Disease Control. Update: Perinatally acquired HIV/AIDS-United States, 1997. MMWR Morb Mortal Wkly Rep 1997;46:1086-92.
2. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O’Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
3. Mofenson LM. A critical review of studies evaluating the relationship of mode of delivery to perinatal transmission of human immunodeficiency virus. Pediatr Infect Dis J 1995;14:169-77.
4. The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. N Engl J Med 1999;340:977-87.
5. Goedert JJ, Duliège AM, Amos CI, Felton S, Biggar RJ. High risk of HIV-1 infection for first-born twins. Lancet 1991;338:1471-5.
6. Shaffer N, Roongpisuthipong A, Siriwasin W, Chotpitayasunondh T, Chearskul S, Young NL, et al. Maternal virus load and perinatal human immunodeficiency virus type I subtype E transmission, Thailand. J Infect Dis 1999;179:590-9.
7. Semprini AE, Castagna C, Ravizza M, Fiore S, Savasi V, Muggiasca ML, et al. The incidence of complications after caesarean section in 156 HIV-positive women. AIDS 1995;9:913-7.
8. Stringer JSA, Rouse DJ, Goldenberg RL. Prophylactic cesarean delivery for the prevention of perinatal human immunodeficiency virus transmission. The case for restraint. JAMA 1999;281:1946-9.
9. The European Mode of Delivery Collaboration. Elective cesarean section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomised clinical trial. Lancet 1999;353:1035-9.
10. Centers for Disease Control and Prevention. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. MMWR Morb Mortal Wkly Rep 1998;47:1-30.
11. Ayers KM, Clive D, Tucker WE Jr, Hajian G, de Miranda P. Nonclinical toxicology studies with zidovudine: Genetic toxicity tests and carcinogenicity bioassays in mice and rats. Fundam Appl Toxicol 1996;32:148-58.
12. Riley LE, Greene MF. Elective cesarean delivery to reduce the transmission of HIV [editorial]. N Engl J Med 1999;340:1032-3.